OrbiMed Advisors Israel II Ltd's Net Worth

-$20.8 Million

Estimate Recalculated May 3, 2024 03:02PM EST

Who is OrbiMed Advisors Israel II Ltd?

OrbiMed Advisors Israel II Ltd does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., LogicBio Therapeutics, Inc., 89bio, Inc., Galecto, Inc., and SteadyMed Ltd..

SEC CIK

OrbiMed Advisors Israel II Ltd's CIK is 0001682093

Past Insider Trading and Trends

2020 was OrbiMed Advisors Israel II Ltd's most active year for acquiring shares with 13 total transactions. OrbiMed Advisors Israel II Ltd's most active month to acquire stocks was the month of October. 2023 was OrbiMed Advisors Israel II Ltd's most active year for disposing of shares, totalling 36 transactions. OrbiMed Advisors Israel II Ltd's most active month to dispose stocks was the month of March. 2020 saw OrbiMed Advisors Israel II Ltd paying a total of $19,888,887.00 for 11,363,189 shares, this is the most they've acquired in one year. In 2018 OrbiMed Advisors Israel II Ltd cashed out on 18,093,681 shares for a total of $18,938,034.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc. (ACET) Snapshot price: $3.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.01%
3.13M
$2.40
$7,500,000.00
9.77M
Jan 25
Form 4
+12.10%
875K
$2.09
$1,828,750.00
8.11M
Jun 27
Form 4
+765.30%
214.28K
$14.00
$2,999,990.00
242.28K
Dec 10
Form 4
+10.25%
524.35K
$13.00
$6,816,537.00
5.64M
Feb 12
Form 4
∞
6.02M
—
—
6.02M
Sep 15 - Sep 17
Form 3
—
0
—
—
0
No matching records found

LogicBio Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.91%
1.48M
$6.00
$8,888,892.00
7.95M
Oct 1
Form 4
∞
6.47M
$10.00
—
6.47M
Oct 23
Form 3
—
0
—
—
0
No matching records found

89bio, Inc. (ETNB) Snapshot price: $8.385

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.27%
-70.57K
$8.39
-$592,383.56
5.5M
Jan 25 - Jan 26
Form 4
-6.87%
-275.00K
$28.00
-$7,700,000.00
3.73M
Sep 21
Form 4
+254.06%
3.39M
$16.00
$6,700,000.00
4.73M
Nov 11 - Nov 13
Form 3
—
0
—
—
0
No matching records found

Galecto, Inc. (GLTO) Snapshot price: $0.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-26.87%
-822.68K
$0.75
-$617,010.00
2.24M
Aug 15
Form 4
-6.29%
-209.40K
$3.00
-$628,200.00
3.12M
Jul 31
Form 4
-1.16%
-39.20K
$2.92
-$114,464.00
3.33M
Jul 25
Form 4
-5.46%
-194.70K
$2.40
-$467,280.00
3.37M
Jul 13
Form 4
-0.63%
-68.48K
$1.88
-$128,256.61
10.76M
Apr 13 - Apr 17
Form 4
-0.61%
-67.54K
$1.81
-$121,356.87
10.96M
Apr 10 - Apr 12
Form 4
-1.37%
-102.63K
$2.09
-$221,993.70
7.41M
Apr 5 - Apr 6
Form 4
+132.14%
3.8M
$15.00
$10,999,995.00
6.68M
Sep 25 - Nov 2
Form 3
—
0
—
—
0
No matching records found

SteadyMed Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.25M
$4.46
-$18,938,034.16
0
Aug 30
Form 4
+38.21%
1.17M
$5.90
$6,926,600.00
4.25M
Apr 25
Form 3
—
0
—
—
0
No matching records found